Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Biol Psychiatry. 2012 Oct 15. pii: S0006-3223(12)00800-1. doi: 10.1016/j.biopsych.2012.08.025. [Epub ahead of print]

    Chronic Intranasal Oxytocin Causes Long-Term Impairments in Partner Preference Formation in Male Prairie Voles.

    Source

    From the Department of Psychology (KLB, AMP, OGC, MHL, CDG, GMD, CRY), University of California, and California National Primate Research Center (KLB, SPM), Davis; and John F. Kennedy High School (MHL), and MIND Institute (MS), Sacramento, California; and Department of Psychiatry (SJ), University of Illinois at Chicago, Chicago, Illinois. Electronic address: klbales@ucdavis.edu.

    Abstract

    BACKGROUND:

    Oxytocin (OT) is a hormone shown to be involved in social bonding in animal models. Intranasal OT is currently in clinical trials for use in disorders such as autism and schizophrenia. We examined long-term effects of intranasal OT given developmentally in the prairie vole (Microtus ochrogaster), a socially monogamous rodent, often used as an animal model to screen drugs that have therapeutic potential for social disorders.

    METHODS:

    We treated voles with one of three dosages of intranasal OT, or saline, from day 21 (weaning) through day 42 (sexual maturity). We examined both social behavior immediately following administration, as well as long-term changes in social and anxiety behavior after treatment ceased. Group sizes varied from 8 to 15 voles (n = 89 voles total).

    RESULTS:

    Treatment with OT resulted in acute increases in social behavior in male voles with familiar partners, as seen in humans. However, long-term developmental treatment with low doses of intranasal OT resulted in a deficit in partner preference behavior (a reduction of contact with a familiar opposite-sex partner, used to index pair-bond formation) by male voles.

    CONCLUSIONS:

    Long-term developmental treatment with OT may show results different to those predicted by short-term studies, as well as significant sex differences and dosage effects. Further animal study is crucial to determining safe and effective strategies for use of chronic intranasal OT, especially during development.

    Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

    PMID:
    23079235
    [PubMed - as supplied by publisher]
    PMCID:
    PMC3556198
    [Available on 2014/4/15]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk